BiotechTube
Home/RosVivo Therapeutics/David Craig
DC

David Craig

Chief Executive Officer

RosVivo Therapeutics

Therapeutic Areas

Metabolic DiseasesDiabetesObesityNAFLDGastrointestinal Disorders

RosVivo Therapeutics Pipeline

DrugIndicationPhase
RSVI-301Diabetes (with planned expansion to Obesity, NAFLD, GI disorders)Pre-clinical
RSVI-302Diabetes and ObesityPre-clinical

Leadership Team at RosVivo Therapeutics

SR
Seungil Ro
President and Chief Scientific Officer
SM
Sandra M. Poudrier
Chief Operating Officer
View full RosVivo Therapeutics profile